manage a centralized, comprehensive, and descriptive database of the Government's real property portfolio. GSA, in collaboration with the FRPC, determined that enhancing the existing FRPP with numerous modifications and upgrades was the most cost-effective, efficient solution. The goals of the centralized database are to 1) improve decision-making with more accurate and reliable data; 2) provide the ability to benchmark Federal real property assets; and 3) consolidate government real property data collection into one inventory system. In grant application 2 R01 CA40453-14 (p. 9), this article was used as justification for proposed research on BRCA1 and related proteins that may be required for transcription-coupled DNA repair of oxidative DNA damage. Data from the research reported in this paper was also used as preliminary data (Figure 2 , p. 16) to support proposed experiments on BRCA1.
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